Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
27.46
+4.57 (19.97%)
At close: Dec 5, 2025, 4:00 PM EST
26.66
-0.80 (-2.91%)
After-hours: Dec 5, 2025, 7:58 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $36.45 million as of December 5, 2025. Its market cap has increased by 358.92% in one year.
Market Cap
36.45M
Enterprise Value
28.73M
1-Year Change
358.92%
Ranking
Category
Stock Price
$27.46
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $36.45M, a decrease of -90.12%. That is a compound annual growth rate of -36.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 30.38M | 396.08% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |